South Africa: Link Between Traditional Beer, Storage of Maize and Oesophageal Cancer in the Eastern Cape Revealed
[Daily Maverick] Researchers at Walter Sisulu University have found a link between the high incidence of oesophageal cancer in the province and the consumption of umqombothi (traditional beer). They say the risk of this type of cancer is increased by the consumption of umqombothi, coupled with a fungus found in inappropriately stored maize. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 15, 2022 Category: African Health Source Type: news

‘One of the most widely consumed beverages around the world’ linked to oesophageal cancer
AS THE weather gets colder, more people will be reaching for a hot drink to warm up. However, a new study suggests reaching for a hot cup of coffee could have negative health consequences and even increase your risk of cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - August 26, 2022 Category: Consumer Health News Source Type: news

Drinking coffee may raise risk of oesophageal cancer... but only if it's piping hot, study claims
People who are genetically more likely to drink coffee may have an increased risk of oesophageal cancer but not other cancer types, a study by researchers at the University of Cambridge claims. (Source: the Mail online | Health)
Source: the Mail online | Health - August 25, 2022 Category: Consumer Health News Source Type: news

New double-drug therapy gives fresh hope to Brits with oesophagus cancer
New trial results suggest that patients given the immunotherapy medicine tislelizumab alongside chemotherapy are likely to live much longer than those given chemotherapy alone. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2022 Category: Consumer Health News Source Type: news

MET-PET detects early patient response to CIRT
PET/CT imaging with carbon-11 methionine (MET) appears promising for detectin...Read more on AuntMinnie.comRelated Reading: Midtherapy PET/CT predicts response in patients with esophageal cancer Dual-tracer PET/CT shows promise in cancer imaging How can the clinical potential of PET/MRI be unlocked? Toshiba gets Japanese radiotherapy install Carbon ion therapy: To gate or not? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 17, 2022 Category: Radiology Source Type: news

Chemoradiotherapy Safe, Effective for High-Risk Esophageal SCC Chemoradiotherapy Safe, Effective for High-Risk Esophageal SCC
For patients with squamous cell carcinoma (SCC), outcomes with chemoradiotherapy were comparable to those with esophagectomy. The study was published as a preprint and has not been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

UK scientists invent artificial eye which pics up a deadly throat cancer
Professor Rehan Haidry, a of University College London, who offers the procedure, said: 'If we pick up oesophageal cancer early, we can treat it with minimally invasive surgery.' (Source: the Mail online | Health)
Source: the Mail online | Health - July 25, 2022 Category: Consumer Health News Source Type: news

Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer
Results demonstrate a significant increase in the detection rate of neoplasia when Cellvizio is used as an adjunct to the standard of care, underscoring the key role of advanced imaging in slowing the rapid growth of esophageal cancer Meta-analysis buil... Devices, Diagnostics, Oncology Mauna Kea Technologies, Cellvizio, Barrett’s Esophagus, Esophageal Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2022 Category: Pharmaceuticals Source Type: news

Cancer warning: The hot drink that may be associated with a 90% higher risk of cancer
CANCER risk can be modified through the lifestyle decisions you make. One of the more alarming findings to date is that knocking back a particularly hot drink may hike your risk of oesophageal cancer by 90 percent. (Source: Daily Express - Health)
Source: Daily Express - Health - July 6, 2022 Category: Consumer Health News Source Type: news

Cancer symptoms: The ‘common’ sign when you eat that appears in the ‘early stages'
WHILE there are various symptoms linked to oesophageal cancer, their generic nature might make them difficult to spot. As this type of cancer claims thousands of lives yearly, being able to recognise the symptoms could help spot the diagnosis early. An expert shares a "common" sign that appears in the "early stages". (Source: Daily Express - Health)
Source: Daily Express - Health - June 26, 2022 Category: Consumer Health News Source Type: news

Kim Kardashian shares Father's Day tributes to Ye and her late dad
The 41-year-old reality star was 22 when her father died, age 59, from esophageal cancer in 2003 (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2022 Category: Consumer Health News Source Type: news

How Do You Detect Esophageal Cancer?
Title: How Do You Detect Esophageal Cancer?Category: Diseases and ConditionsCreated: 6/16/2022 12:00:00 AMLast Editorial Review: 6/16/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 16, 2022 Category: Cancer & Oncology Source Type: news

Main Causes of Esophageal Cancer
Title: Main Causes of Esophageal CancerCategory: Diseases and ConditionsCreated: 4/23/2021 12:00:00 AMLast Editorial Review: 6/8/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 8, 2022 Category: Cancer & Oncology Source Type: news

Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA ® (erdafitinib) in Patients with Advanced Solid Tumors with FGFR Alterations
CHICAGO, ILLINOIS, June 7, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the pivotal Phase 2 RAGNAR study evaluating the investigational use of BALVERSA® (erdafitinib), a fibroblast growth factor receptor (FGFR) kinase inhibitor, in patients with advanced solid tumors with prespecified FGFR alterations. At a planned interim analysis (IA), responses were observed across a variety of FGFR-driven solid tumors for patients who had exhausted standard treatment options prior to being treated with BALVERSA®.[1] These results will be featured in an oral presentation (...
Source: Johnson and Johnson - June 7, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Rates of esophageal cancer among middle-aged Americans doubled over a five year period
The rate of middle-aged Americans developing esophageal cancer nearly doubled from 2012 to 2017, a new study finds. Researchers were unable to nail down an exact cause for this increase. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2022 Category: Consumer Health News Source Type: news